Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Sturm

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional StudyCameron Crowell, Nikhil P Mankuzhy, Julie Bennett, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell|December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for GliomagenesisCarol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
Neuro-Oncology Practice|March 9, 2026
Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working groupMichael Karremann, Tabea Gerdes, Gerrit H Gielen, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
Cancer Cell|October 20, 2012
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastomaDominik Sturm, Hendrik Witt, Volker Hovestadt, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional StudyCameron Crowell, Nikhil P Mankuzhy, Julie Bennett, et al.
Nature|April 17, 2020
Germline Elongator mutations in Sonic Hedgehog medulloblastomaSebastian M Waszak, Giles W Robinson, Brian L Gudenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell|December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for GliomagenesisCarol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
Neuro-Oncology Practice|March 9, 2026
Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working groupMichael Karremann, Tabea Gerdes, Gerrit H Gielen, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
Cancer Cell|October 20, 2012
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastomaDominik Sturm, Hendrik Witt, Volker Hovestadt, et al.
Pageof 13